about
N-dihydrogalactochitosan as a potent immune activator for dendritic cells.New development in CAR-T cell therapy.Review: Current clinical applications of chimeric antigen receptor (CAR) modified T cells.Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment.Chimeric Antigen Receptor T-Cells (CAR T-Cells) for Cancer Immunotherapy - Moving Target for Industry?Current status and future directions of cancer immunotherapy.The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
P2860
Q36234323-F5B8AC78-ACD8-453B-AE93-9939744A5664Q37658246-DA81C946-4FE2-40F7-94FC-45BFD1F39610Q38945853-19F92F26-44A8-45B8-879B-FF242EECB438Q39280002-FBC7F90E-625F-44B2-A5A3-46B103A95CE2Q55043332-0BA0E9C8-3D12-4CB3-B48D-17DBDB00F87DQ55070491-6C1E4093-33C0-4FD4-8712-B6A34DC6559EQ57177485-01A348EA-2EDB-4685-B55B-6831BF7F9831
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Overcoming Antigen Escape with CAR T-cell Therapy.
@en
type
label
Overcoming Antigen Escape with CAR T-cell Therapy.
@en
prefLabel
Overcoming Antigen Escape with CAR T-cell Therapy.
@en
P2860
P1433
P1476
Overcoming Antigen Escape with CAR T-cell Therapy.
@en
P2093
Hollie J Jackson
Renier J Brentjens
P2860
P304
P356
10.1158/2159-8290.CD-15-1275
P577
2015-12-01T00:00:00Z